##FILTER=off-target=Variant marked as 'off-target'.
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##SAMPLE=<ID=NA12878_03,Gender=n/a,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Other diseases,DiseaseStatus=affected>
##DESCRIPTION=genotype=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=ESP_sub=Sub-population allele frequency (EA,AA) in NHLBI Exome Sequencing project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (difference in percent/reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	ESP_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC
chr1	6526183	6526183	G	A	hom		QUAL=3484;DP=113;AF=1.00;MQM=60	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,TNFRSF25:ENST00000351959:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,TNFRSF25:ENST00000377782:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::	611101 [PLEKHG5 (confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067/Charcot-Marie-Tooth disease,recessive intermediate C,615376];	297904 [benign DISEASE=Distal spinal muscular atrophy];			rs3007417	0.2023	0.1849	1067,	0.5065,0.0514,0.0000,0.0711,0.0791	0.0577,0.3759	-0.6580			0.06,0.14	0.41					
chr1	10460485	10460485	T	C	het		QUAL=769;DP=79;AF=0.47;MQM=60	PGD	synonymous	PGD:ENST00000270776:synonymous_variant:LOW:exon3/13:c.120T>C:p.Asp40=:PF03446,PGD:ENST00000538557:synonymous_variant:LOW:exon3/13:c.81T>C:p.Asp27=:PF03446,PGD:ENST00000541529:synonymous_variant:LOW:exon3/12:c.120T>C:p.Asp40=:PF03446					rs1049887	0.2338	0.2810	1038,	0.0896,0.3460,0.2870,0.2975,0.2375	0.3027,0.0976	0.5280			0.68,0.90	0.94					
chr1	11856378	11856378	G	A	het		QUAL=2227;DP=162;MQM=60	MTHFR	missense	MTHFR:ENST00000376583:missense_variant:MODERATE:exon5/12:c.788C>T:p.Ala263Val:PF02219,MTHFR:ENST00000376585:missense_variant:MODERATE:exon6/13:c.788C>T:p.Ala263Val:PF02219,MTHFR:ENST00000376590:missense_variant:MODERATE:exon5/12:c.665C>T:p.Ala222Val:PF02219,MTHFR:ENST00000376592:missense_variant:MODERATE:exon4/11:c.665C>T:p.Ala222Val:PF02219	607093 [MTHFR (provisional) Homocystinuria due to MTHFR deficiency,236250/Schizophrenia,susceptibility to,181500/Vascular disease,susceptibility to/Neural tube defects,susceptibility to,601634/Thromboembolism,susceptibility to,188050];	3520 [drug response DISEASE=Neoplasm of stomach,Gastrointestinal stroma tumor,MTHFR deficiency, thermolabile type,Neural tube defects, folate-sensitive,not specified,carboplatin response - Efficacy,cyclophosphamide response - Toxicity/ADR,methotrexate response - Dosage, Efficacy, Toxicity/ADR,not provided];	CM950819 [CLASS=DFP MUT=ALT PHEN="Cardiovascular disease association with" GENE=MTHFR];		rs1801133	0.2454	0.3143	1159,	0.1055,0.5031,0.2937,0.3397,0.1444	0.3469,0.1217	9.0450	D,D,D,D	D,D,D,D	0.98,0.98	3.62	0.84				
chr1	31905889	31905889	-	CAG	hom		QUAL=7465;DP=238;AF=0.97;MQM=60	SERINC2	inframe_insertion	SERINC2:ENST00000373709:inframe_insertion:MODERATE:exon9/10:c.1102_1104dup:p.Gln368dup:PF03348,SERINC2:ENST00000373710:inframe_insertion:MODERATE:exon10/11:c.1129_1131dup:p.Gln377dup:PF03348,SERINC2:ENST00000536384:inframe_insertion:MODERATE:exon9/10:c.1114_1116dup:p.Gln372dup:PF03348,SERINC2:ENST00000536859:inframe_insertion:MODERATE:exon9/10:c.1114_1116dup:p.Gln372dup:PF03348					rs3050461	0.7390	0.8120	9932,	0.6902,0.5467,0.5341,0.7081,0.5624	0.8396,0.7951					0.71					
chr1	57422472	57422472	G	A	het		QUAL=2962;DP=205;AF=0.55;MQM=60	C8B	stop_gained	C8B:ENST00000371237:stop_gained:HIGH:exon3/12:c.361C>T:p.Arg121Ter:,C8B:ENST00000535057:stop_gained:HIGH:exon4/13:c.175C>T:p.Arg59Ter:,C8B:ENST00000543257:stop_gained:HIGH:exon4/13:c.205C>T:p.Arg69Ter:	120960 [C8B (confirmed) C8 deficiency,type II,613789];	35593 [pathogenic DISEASE=Complement component 8 deficiency type 2];	CM952410 [CLASS=DM MUT=ALT PHEN="Complement C8b deficiency" GENE=C8B];		rs150022116		0.0001		0.0001,0.0001,0.0001,0.0002,0.0001		1.0610			0.29,0.98	8.09					COSM4577467
chr1	62740781	62740781	A	-	het	off-target	QUAL=265;DP=121;AF=20.55;MQM=60	KANK4	intron	KANK4:ENST00000354381:intron_variant:MODIFIER:exon2/8:c.17-3520del::,KANK4:ENST00000371153:intron_variant:MODIFIER:exon2/9:c.17-22del::					rs761923018		0.1147	0,	0.0808,0.1637,0.1023,0.1015,0.1765	0.1190,0.1121	0.6420				0.73					
chr1	120612003	120612004	GG	-	het		QUAL=3950;DP=2047;AF=0.20;MQM=48	NOTCH2	frameshift	NOTCH2:ENST00000256646:frameshift_variant:HIGH:exon1/34:c.17_18del:p.Pro6ArgfsTer27:	600275 [NOTCH2 (provisional) Alagille syndrome 2,610205/Hajdu-Cheney syndrome,102500];	218795 [benign DISEASE=not specified];			rs372504208,rs864309621		0.1800	0,	0.2102,0.1169,0.1142,0.2152,0.1600		0.6960				3.04					COSM132830
chr1	144206548	144206548	C	T	het	gene_blacklist	QUAL=3611;DP=400;AF=0.50;MQM=60	NBPF8	missense	NBPF8:ENST00000356801:missense_variant:MODERATE:exon19/24:c.131C>T:p.Thr44Ile:PF06758					rs201297880		0.0000	0,			0.8920	T	B	0.00,0.05	0.13	0.05				
chr1	156565049	156565049	-	AC	hom		QUAL=6110;DP=216;AF=1.00;MQM=60	GPATCH4	frameshift	GPATCH4:ENST00000368232:frameshift_variant:HIGH:exon8/8:c.1068_1069insGT:p.Phe357ValfsTer91:,GPATCH4:ENST00000438976:frameshift_variant:HIGH:exon8/8:c.1083_1084insGT:p.Phe362ValfsTer?:					rs72559129	0.9942	0.9986	15299,	0.9811,0.9984,1.0000,1.0000,0.9999	0.9965,0.9812					2.34					
chr1	171112490	171112490	C	T	hom		QUAL=870;DP=32;AF=0.97;MQM=60	FMO6P	stop_gained	FMO6P:ENST00000236166:stop_gained:HIGH:exon2/8:c.313C>T:p.Gln105Ter:PF00743					rs1736565	0.6380	0.6110	5941,	0.7696,0.6787,0.5946,0.5280,0.6092		0.2800			0.75,0.99	7.16					
chr1	183191250	183191250	C	T	het		QUAL=1289;DP=109;AF=0.48;MQM=60	LAMC2	stop_gained	LAMC2:ENST00000264144:stop_gained:HIGH:exon6/23:c.667C>T:p.Arg223Ter:,LAMC2:ENST00000493293:stop_gained:HIGH:exon6/22:c.667C>T:p.Arg223Ter:	150292 [LAMC2 (confirmed) Epidermolysis bullosa,junctional,Herlitz type,226700/Epidermolysis bullosa,junctional,non-Herlitz type,226650];	188791 [likely pathogenic DISEASE=Junctional epidermolysis bullosa gravis of Herlitz];	CM043021 [CLASS=DM MUT=ALT PHEN="Epidermolysis bullosa junctional" GENE=LAMC2];		rs753268823		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000		0.6350			0.26,0.97	6.60					
chr2	38301847	38301847	C	T	het		QUAL=4465;DP=321;AF=0.53;MQM=60	CYP1B1	missense	CYP1B1:ENST00000260630:missense_variant:MODERATE:exon2/3:c.685G>A:p.Glu229Lys:PF00067,CYP1B1:ENST00000407341:missense_variant:MODERATE:exon2/3:c.685G>A:p.Glu229Lys:PF00067	601771 [CYP1B1 (confirmed) Glaucoma 3A,primary open angle,congenital,juvenile,or adult onset,231300/Anterior segment dysgenesis 6,multiple subtypes,617315];	68467 [conflicting interpretations of pathogenicity, other DISEASE=Congenital ocular coloboma,Primary congenital glaucoma,not provided];	CM014173 [CLASS=DM MUT=ALT PHEN="Glaucoma primary congenital" GENE=CYP1B1];		rs57865060	0.0104	0.0110	0,	0.0010,0.0018,0.0000,0.0080,0.0495	0.0050,0.0011	3.7110	D,D	B,B	0.80,0.97	3.51	0.40				
chr2	168041152	168041152	T	C	het	gene_blacklist	QUAL=717;DP=66;AF=0.48;MQM=60	XIRP2	intron,splice_donor	XIRP2:ENST00000295237:intron_variant:MODIFIER:exon2/9:c.563-26093T>C::,XIRP2:ENST00000409043:intron_variant:MODIFIER:exon3/9:c.563-26093T>C::,XIRP2:ENST00000409195:intron_variant:MODIFIER:exon3/10:c.563-26093T>C::,XIRP2:ENST00000409728:splice_donor_variant:HIGH:exon4/10:c.661+2T>C::,XIRP2:ENST00000409756:intron_variant:MODIFIER:exon2/8:c.563-26093T>C::,XIRP2:ENST00000420519:splice_donor_variant:HIGH:exon3/9:c.661+2T>C::				L1MEg1	rs16853169	0.1026	0.0943	145,	0.1331,0.0529,0.0818,0.0903,0.1641		-0.5410			0.01,0.15	0.10		-199.51% (3.89>-3.87)		0.000/0.000	
chr3	38645420	38645420	T	C	het		QUAL=3985;DP=361;AF=0.45;MQM=60	SCN5A	missense	SCN5A:ENST00000333535:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000413689:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000414099:missense_variant:MODERATE:exon11/26:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000423572:missense_variant:MODERATE:exon11/27:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000425664:missense_variant:MODERATE:exon12/27:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000443581:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000449557:missense_variant:MODERATE:exon11/26:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000450102:missense_variant:MODERATE:exon11/26:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000451551:missense_variant:MODERATE:exon12/27:c.1673A>G:p.His558Arg:PF11933,SCN5A:ENST00000455624:missense_variant:MODERATE:exon11/27:c.1673A>G:p.His558Arg:PF11933	600163 [SCN5A (confirmed) Long QT syndrome-3,603830/Brugada syndrome 1,601144/Heart block,progressive,type IA,113900/Heart block,nonprogressive,113900/Ventricular fibrillation,familial,1,603829/Sick sinus syndrome 1,608567/Cardiomyopathy,dilated,1E,601154/Sudden infant death syndrome,susceptibility to,272120/Atrial fibrillation,familial,10,614022];	48289 [benign/likely benign DISEASE=Long QT syndrome,Sick sinus syndrome,Paroxysmal familial ventricular fibrillation,Brugada syndrome,Romano-Ward syndrome,not specified,Progressive familial heart block,Cardiovascular phenotype,Dilated Cardiomyopathy, Dominant,not provided]; 440849 [pathogenic DISEASE=Progressive familial heart block type 1A];	CM031355 [CLASS=DFP MUT=ALT PHEN="Phenotype modifier association with" GENE=SCN5A];		rs1805124	0.2304	0.2453	956,	0.2930,0.2163,0.0940,0.2301,0.2473	0.2321,0.2748	1.6570	T,T,T,T,T,T,T,T,T,T	B,B,B,B,B,B,B,B,B,B	0.02,0.93	0.63	0.29				
chr3	142231062	142231062	-	A	het	off-target	QUAL=5;DP=31;AF=0.16;MQM=56	ATR	intron	ATR:ENST00000350721:intron_variant:MODIFIER:exon27/46:c.4852+39dup::,ATR:ENST00000383101:intron_variant:MODIFIER:exon26/45:c.4660+39dup::	601215 [ATR (confirmed) Seckel syndrome 1,210600/Cutaneous telangiectasia and cancer syndrome,familial,614564];			(A)n	rs771446118		0.4620	2024,	0.1852,0.1553,0.1661,0.1033,0.0865						-0.07					
chr7	130297120	130297120	A	-	hom		QUAL=1215;DP=53;AF=0.92;MQM=60	COPG2	intron	COPG2:ENST00000445977:intron_variant:MODIFIER:exon7/8:c.493-11del::					rs34699820,rs564963249	0.7376	0.7970	9392,	0.6823,0.6274,0.6586,0.7728,0.6570		0.0310				0.37					
chr11	117772955	117772955	T	C	het		QUAL=2020;DP=173;AF=0.47;MQM=60	TMPRSS13	stop_retained	TMPRSS13:ENST00000524993:stop_retained_variant:LOW:exon13/13:c.1703A>G:p.Ter568=:,TMPRSS13:ENST00000528626:stop_retained_variant:LOW:exon12/12:c.1598A>G:p.Ter533=:					rs73020481	0.0615	0.0732	78,	0.0698,0.0434,0.0055,0.0832,0.0570	0.0867,0.0662	0.2750			0.01,0.93	0.38					
chr12	6397417	6397417	C	G	het	off-target	QUAL=30;DP=361;AF=0.45;MQM=60		intergenic	::intergenic_variant:MODIFIER::::				L1M4							0.1350			0.01,0.19	0.15					
chr15	43701947	43701947	A	-	het		QUAL=368;DP=58;AF=0.43;MQM=60	TP53BP1	splice_region&intron	TP53BP1:ENST00000263801:splice_region_variant&intron_variant:LOW:exon24/27:c.5291-8del::,TP53BP1:ENST00000382039:splice_region_variant&intron_variant:LOW:exon23/26:c.5156-8del::,TP53BP1:ENST00000382044:splice_region_variant&intron_variant:LOW:exon24/27:c.5306-8del::,TP53BP1:ENST00000450115:splice_region_variant&intron_variant:LOW:exon24/27:c.5300-8del::					rs56813954	0.2502	0.3494	729,	0.1821,0.3645,0.4192,0.3508,0.3898		0.7510				0.60					COSM1608394,COSM5493271
chr16	48329922	48329922	-	T	het		QUAL=297;DP=61;AF=0.33;MQM=60	LONP2	splice_region&intron	LONP2:ENST00000285737:splice_region_variant&intron_variant:LOW:exon8/14:c.1384-3dup::,LONP2:ENST00000535754:splice_region_variant&intron_variant:LOW:exon7/13:c.1252-3dup::					rs766396809										0.77					
chr16	88921634	88921634	C	G	het		QUAL=520;DP=69;AF=0.39;MQM=60	GALNS	intron,splice_donor,3'UTR	GALNS:ENST00000268695:intron_variant:MODIFIER:exon1/13:c.120+1532G>C::,GALNS:ENST00000542788:splice_donor_variant:HIGH:exon2/12:c.94+1G>C::,GALNS:ENST00000568311:3_prime_UTR_variant:MODIFIER:exon3/3:c.*161G>C::	612222 [GALNS (confirmed) Mucopolysaccharidosis IVA,253000];				rs34150867	0.4008	0.3799	2512,	0.5924,0.2434,0.4533,0.2966,0.2367		-0.7040			0.00,0.04	-0.17		-150.28% (5.50>-2.77)		0.000/0.000	
chr17	41244936	41244936	G	A	het		QUAL=2131;DP=132;AF=0.58;MQM=60	BRCA1	missense,intron	BRCA1:ENST00000309486:missense_variant:MODERATE:exon9/22:c.1724C>T:p.Pro575Leu:PF04873,BRCA1:ENST00000346315:missense_variant:MODERATE:exon10/19:c.2612C>T:p.Pro871Leu:PF04873,BRCA1:ENST00000351666:intron_variant:MODIFIER:exon6/18:c.548-1887C>T::,BRCA1:ENST00000352993:intron_variant:MODIFIER:exon9/21:c.671-1887C>T::,BRCA1:ENST00000354071:missense_variant:MODERATE:exon10/18:c.2612C>T:p.Pro871Leu:PF04873,BRCA1:ENST00000357654:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:PF04873,BRCA1:ENST00000468300:intron_variant:MODIFIER:exon10/21:c.787+1825C>T::,BRCA1:ENST00000471181:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:PF04873,BRCA1:ENST00000491747:intron_variant:MODIFIER:exon10/22:c.787+1825C>T::,BRCA1:ENST00000493795:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:PF04873,BRCA1:ENST00000586385:intron_variant:MODIFIER:exon1/7:c.5-28968C>T::,BRCA1:ENST00000591534:intron_variant:MODIFIER:exon1/10:c.-43-18398C>T::,BRCA1:ENST00000591849:intron_variant:MODIFIER:exon1/4:c.-99+32352C>T::	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370/Pancreatic cancer,susceptibility to,4,614320/Fanconi anemia,complementation group S,617883];	41812 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,not specified,not provided];	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1];		rs799917		0.4855	4255,	0.8255,0.3468,0.3773,0.3335,0.5324	0.3359,0.8000	4.2470	T,T, , ,T,T, ,T, ,T, , , 	B,B, , ,B,B, ,B, ,B, , , 	0.02,0.89	1.87	0.14				COSM148278
chrX	93983960	93983960	G	T	hom		QUAL=2131;DP=132;AF=0.58;MQM=60		intergenic	::intergenic_variant:MODIFIER::::				AluSx	rs12216940	0.0056	0.0082	1,62			0.2310			0.01,0.10	0.01					
